Madhurendra Singh

Madhurendra Singh is an Associate Principal Scientist at Sprint Bioscience since November 2020, where the focus is on the development of novel targeted anti-cancer therapies, especially reactivators of the p53 tumor suppressor function. Previously, Madhurendra served as a Senior Scientist at Karolinska Institutet from January 2015 to December 2020, working as a Postdoctoral Researcher on related cancer therapy projects. Madhurendra completed a Ph.D. in Biochemistry at Heinrich Heine Universität, gaining insights into G-protein mediated cellular signaling in endothelial biology and circadian clock function from April 2010 to January 2015. Prior to that, Madhurendra held a CSIR-JRF position at Jawaharlal Nehru University, focusing on the role of beta C1 (Gemini virus) in post-translational gene silencing from August 2009 to March 2010. Academic qualifications include a Master's degree in Life Science from the School of Life Science, JNU, obtained between 2007 and 2009, and a Bachelor's degree in Botany and Chemistry from M.G.P.G College, Gorakhpur, completed from 2003 to 2006.